Low-dose aspirin may reduce breast cancer risk

11:11 EDT 19 Jun 2017 | Healio

Women with type 2 diabetes who are taking low-dose aspirin had a lower occurrence of breast cancer than those not taking aspirin, according to research recently published in the Journal of Women’s Health. “Low-dose aspirin is commonly used for preventing [CVD] in people with diabetes, but its association with cancer remains controversial,” Yi-Sun Yang, MD, PhD, School of Medicine, Chung Shan Medical University, Taiwan, and colleagues wrote. “Prospective studies have yielded mixed results; aspirin has been reported to have no association with, reduce the risk of, and increase the risk of breast cancer. Most of these studies have focused on the general population, and no study [has] focused exclusively on diabetes. Diabetes is equivalent to CVD, and the prescription rate for aspirin in the secondary prevention of CVD is [approximately] 90%.”

Original Article: Low-dose aspirin may reduce breast cancer risk


More From BioPortfolio on "Low-dose aspirin may reduce breast cancer risk"

Quick Search


Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...